CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Ruxolitinib Plus Pomalidomide in Myelofibrosis: Updated Results from the Mpnsg-0212 Trial (NCT01644110)
Authors
Markus Bangerter
Hartmut Doehner
+18 more
Konstanze Doehner
Martin Griesshammer
Holger Hebart
Florian H. Heidel
Andreas Hochhaus
Thomas Kindler
Rebecca Kirschbaum
Steffen Koschmieder
Robert Moehle
Regina Reim
Andreas Reiter
Christof Scheid
Richard F. Schlenk
Frank Stegelmann
Ulrike Sutter
Katrin Vetter
Nikolas von Bubnoff
Denise Wolleschak
Publication date
1 January 2016
Publisher
'American Society of Hematology'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Kölner UniversitätsPublikationsServer
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:USBKOELN.ub.uni-koeln.de:2...
Last time updated on 06/12/2020